Hesitant but vaccinated: assessing COVID-19 vaccine hesitancy among the recently vaccinated

Willis, Don; Selig, James P.; Andersen, Jennifer A.; Hall, Spencer; Hallgren, Emily; Williams, Mark L.; Bryant-Moore, Keneshia; McElfish, Pearl A.

doi:10.1007/s10865-021-00270-6

Cited by 49 publications

(47 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The phenomenon of the 'vaccinated but hesitant' is well described [26]. In one US study, 60% of recently COVID-19 vaccinated individuals expressed some level of hesitancy [27]. Conversely, motivations toward vaccination may not convert to vaccine uptake.…”

Section: Discussionmentioning

confidence: 99%

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Day¹,

Grech²,

Nguyen³

et al. 2022

Vaccines

View full text Add to dashboard Cite

As COVID-19 vaccinations became available and were proven effective in preventing serious infection, uptake amongst individuals varied, including in medically vulnerable populations. This cross-sectional multi-site study examined vaccine uptake, hesitancy, and explanatory factors amongst people with serious and/or chronic health conditions, including the impact of underlying disease on attitudes to vaccination. A 42-item survey was distributed to people with cancer, diabetes, or multiple sclerosis across ten Australian health services from 30 June to 5 October 2021. The survey evaluated sociodemographic and disease-related characteristics and incorporated three validated scales measuring vaccine hesitancy and vaccine-related beliefs generally and specific to their disease: the Oxford COVID-19 Vaccine Hesitancy Scale, the Oxford COVID-19 Vaccine Confidence and Complacency Scale and the Disease Influenced Vaccine Acceptance Scale-Six. Among 4683 participants (2548 [54.4%] female, 2108 [45.0%] male, 27 [0.6%] other; mean [SD] age, 60.6 [13.3] years; 3560 [76.0%] cancer, 842 [18.0%] diabetes, and 281 [6.0%] multiple sclerosis), 3813 (81.5%) self-reported having at least one COVID-19 vaccine. Unvaccinated status was associated with younger age, female sex, lower education and income, English as a second language, and residence in regional areas. Unvaccinated participants were more likely to report greater vaccine hesitancy and more negative perceptions toward vaccines. Disease-related vaccine concerns were associated with unvaccinated status and hesitancy, including greater complacency about COVID-19 infection, and concerns relating to vaccine efficacy and impact on their disease and/or treatment. This highlights the need to develop targeted strategies and education about COVID-19 vaccination to support medically vulnerable populations and health professionals.

show abstract

Section: Discussionmentioning

confidence: 99%

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Day¹,

Grech²,

Nguyen³

et al. 2022

Vaccines

View full text Add to dashboard Cite

show abstract

“…Arce et al, 2021 , Brown et al , Carson, 2021 , Chen and Krieger., 2021 , Kazemian et al, 2021 , Latkin et al, 2021 , Liao and De Maio., 2021 , Liu and GabrielLi, 2021 , Mollalo and Tatar, 2021 , Phelan and Bruce, 2015 , Rane et al, 2022 , Salomon et al, 2021 , Siegel et al, 2021 , Tal et al, 2020 , Willis et al, 2022 , Wright et al, 2014 …”

Section: Uncited Referencesmentioning

confidence: 99%

Racial concentration and dynamics of COVID-19 vaccination in the United States

Wu¹

2022

SSM - Population Health

View full text Add to dashboard Cite

“…A survey in April 2021 indicated that 52% of those reporting they would definitely not have the vaccine in November/December 2020 later accepted it when offered (and 15% of those not yet offered were likely to accept) [ 15 ], while another survey noted a reduction in hesitancy from 26.9% in October 2020 to 16.9% in January/February 2021 [ 23 ], indicating substantial shifts in preferences as the campaign has progressed. In the US, a survey revealed a high prevalence of some degree of hesitancy even among those being vaccinated (60%), with levels varying by age and ethnicity [ 24 ]. We found the probability of going from recorded as declining to being vaccinated was broadly similar across ethnic groups, but slightly higher in the South Asian population.…”

Section: Discussionmentioning

confidence: 99%

Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021

et al. 2022

View full text Add to dashboard Cite

Background Priority patients in England were offered COVID-19 vaccination by mid-April 2021. Codes in clinical record systems can denote the vaccine being declined. Aim We describe records of COVID-19 vaccines being declined, according to clinical and demographic factors. Methods With the approval of NHS England, we conducted a retrospective cohort study between 8 December 2020 and 25 May 2021 with primary care records for 57.9 million patients using OpenSAFELY, a secure health analytics platform. COVID-19 vaccination priority patients were those aged ≥ 50 years or ≥ 16 years clinically extremely vulnerable (CEV) or ’at risk’. We describe the proportion recorded as declining vaccination for each group and stratified by clinical and demographic subgroups, subsequent vaccination and distribution of clinical code usage across general practices. Results Of 24.5 million priority patients, 663,033 (2.7%) had a decline recorded, while 2,155,076 (8.8%) had neither a vaccine nor decline recorded. Those recorded as declining, who were subsequently vaccinated (n = 125,587; 18.9%) were overrepresented in the South Asian population (32.3% vs 22.8% for other ethnicities aged ≥ 65 years). The proportion of declining unvaccinated patients was highest in CEV (3.3%), varied strongly with ethnicity (black 15.3%, South Asian 5.6%, white 1.5% for ≥ 80 years) and correlated positively with increasing deprivation. Conclusions Clinical codes indicative of COVID-19 vaccinations being declined are commonly used in England, but substantially more common among black and South Asian people, and in more deprived areas. Qualitative research is needed to determine typical reasons for recorded declines, including to what extent they reflect patients actively declining.

show abstract

Hesitant but vaccinated: assessing COVID-19 vaccine hesitancy among the recently vaccinated

Cited by 49 publications

References 30 publications

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Racial concentration and dynamics of COVID-19 vaccination in the United States

Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021

Contact Info

Product

Resources

About